The challenges of conducting clinical endpoint studies
Related Experiment Video
Updated: Sep 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Jonathan L Isaacsohn1, Tiffany A Khodadad, Catherine Soldano-Noble
1Medpace, 4850 Smith Road, Cincinnati, OH 45212, USA. j.isaacsohn@medpace.com
Abstract:
In order to evaluate the effects of a particular treatment strategy on mortality and major morbidity within a disease entity, large, multinational, relatively long-term clinical endpoint studies are often conducted. The primary challenge of conducting these studies is to maintain consistency in the interpretation of the clinical endpoints across different geographic areas and over the long time course of the study. The success of a clinical endpoint study depends on understanding the challenges and incorporating the special requirements of these studies into the protocol design and operational procedures throughout the study.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinically Relevant Drug Product Specifications: Methods of Establishment
